Review
swell-Pembrolizumab in the Precision Immunotherapy of Sinonasal Malignancies
Yuting Wu
· 0 citations
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Review
Open access
Aug 2026
Pembrolizumab in the Precision Immunotherapy of Sinonasal Malignancies
Sinonasal carcinoma constitutes a rare subset of head and neck tumors. The majority of patients are diagnosed at a locally advanced stage, and the prognosis following recurrence or metastasis is extremely poor. Pembrolizumab is a humanized monoclonal antibody that targets programmed death-1 (PD-1) and reactivates T-cel...
Yuting Wu
· MedScien · 0 citations